These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

157 related items for PubMed ID: 1519604

  • 1. Long-term beneficial effects of angiotensin-converting enzyme inhibition in patients with nephrotic proteinuria.
    Praga M, Hernández E, Montoyo C, Andrés A, Ruilope LM, Rodicio JL.
    Am J Kidney Dis; 1992 Sep; 20(3):240-8. PubMed ID: 1519604
    [Abstract] [Full Text] [Related]

  • 2. Nephrotic proteinuria without hypoalbuminemia: clinical characteristics and response to angiotensin-converting enzyme inhibition.
    Praga M, Borstein B, Andres A, Arenas J, Oliet A, Montoyo C, Ruilope LM, Rodicio JL.
    Am J Kidney Dis; 1991 Mar; 17(3):330-8. PubMed ID: 1996578
    [Abstract] [Full Text] [Related]

  • 3. Remission of nephrotic syndrome in type 1 diabetes: long-term follow-up of patients in the Captopril Study.
    Wilmer WA, Hebert LA, Lewis EJ, Rohde RD, Whittier F, Cattran D, Levey AS, Lewis JB, Spitalewitz S, Blumenthal S, Bain RP.
    Am J Kidney Dis; 1999 Aug; 34(2):308-14. PubMed ID: 10430979
    [Abstract] [Full Text] [Related]

  • 4. Low-dose angiotensin-converting-enzyme inhibitor captopril to reduce proteinuria in adult idiopathic membranous nephropathy: a prospective study of long-term treatment.
    Rostoker G, Ben Maadi A, Remy P, Lang P, Lagrue G, Weil B.
    Nephrol Dial Transplant; 1995 Aug; 10(1):25-9. PubMed ID: 7724024
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Antiproteinuric effect of angiotensin-converting enzyme inhibition and C5b-9 urinary excretion in membranous glomerulonephritis.
    Praga M, Paz Artal E, Hernández E, Segura J, Moreno MA, Morales JM, Rodicio JL.
    Nephrol Dial Transplant; 1997 Dec; 12(12):2576-9. PubMed ID: 9430854
    [Abstract] [Full Text] [Related]

  • 9. The renal functional and structural consequences of corticosteroid and angiotensin-converting enzyme inhibitor therapy in chronic puromycin aminonucleoside nephropathy.
    Trachtman H, Del Pizzo R, Valderrama E, Gauthier B.
    Pediatr Nephrol; 1990 Sep; 4(5):501-4. PubMed ID: 2242316
    [Abstract] [Full Text] [Related]

  • 10. Add-on angiotensin receptor blocker in patients who have proteinuric chronic kidney diseases and are treated with angiotensin-converting enzyme inhibitors.
    Kanno Y, Takenaka T, Nakamura T, Suzuki H.
    Clin J Am Soc Nephrol; 2006 Jul; 1(4):730-7. PubMed ID: 17699280
    [Abstract] [Full Text] [Related]

  • 11. Angiotensin-converting enzyme (ACE) inhibitors for proteinuria and microalbuminuria in people with sickle cell disease.
    Sasongko TH, Nagalla S, Ballas SK.
    Cochrane Database Syst Rev; 2013 Mar 28; (3):CD009191. PubMed ID: 23543572
    [Abstract] [Full Text] [Related]

  • 12. Antiproteinuric effect of angiotensin-converting-enzyme inhibitors in patients with primary glomerular disease and normal renal function.
    Fabbri A, Cocchi R, Degli Esposti E, Lucatello A, Sturani A, Tampieri G, Fusaroli M.
    Nephrol Dial Transplant; 1990 Mar 28; 5 Suppl 1():81-3. PubMed ID: 2129469
    [Abstract] [Full Text] [Related]

  • 13. Effects of angiotensin-converting enzyme inhibitor and steroid therapy on proteinuria in FSGS: a retrospective study in a single clinic.
    Stiles KP, Abbott KC, Welch PG, Yuan CM.
    Clin Nephrol; 2001 Aug 28; 56(2):89-95. PubMed ID: 11522100
    [Abstract] [Full Text] [Related]

  • 14. Comparison of the influence of angiotensin-converting enzyme inhibitor lisinopril and angiotensin II receptor antagonist losartan in patients with idiopathic membranous nephropathy and nephrotic syndrome.
    Kosmadakis G, Filiopoulos V, Georgoulias C, Tentolouris N, Michail S.
    Scand J Urol Nephrol; 2010 Sep 28; 44(4):251-6. PubMed ID: 20201749
    [Abstract] [Full Text] [Related]

  • 15. [The antiproteinuric action of angiotensin-converting enzyme inhibitors in chronic glomerulonephritis and diabetic nephropathy].
    Kutyrina IM, Tareeva IE, Shestakova MV, Gerasimenko OI, Zverev KV, Rogov VA, Sheremet'eva OV.
    Ter Arkh; 1994 Sep 28; 66(6):19-22. PubMed ID: 7940357
    [Abstract] [Full Text] [Related]

  • 16. [Long-term effect of angiotensin-converting inhibitors in children with proteinuria].
    Camacho Díaz JA, Giménez Llort A, García García L, Jiménez González R.
    An Esp Pediatr; 2001 Sep 28; 55(3):219-24. PubMed ID: 11676896
    [Abstract] [Full Text] [Related]

  • 17. Effect of ACE inhibition by benazepril, enalapril and captopril on chronic and post exercise proteinuria.
    Székács B, Vajo Z, Dachman W.
    Acta Physiol Hung; 1996 Sep 28; 84(4):361-7. PubMed ID: 9328608
    [Abstract] [Full Text] [Related]

  • 18. Factors affecting the long-term outcomes of idiopathic membranous nephropathy.
    Huh H, Lee H, Lee JP, Kim DK, Oh S, Oh YK, Kim YS, Lim CS.
    BMC Nephrol; 2017 Mar 27; 18(1):104. PubMed ID: 28347297
    [Abstract] [Full Text] [Related]

  • 19. IgA nephropathy associated with human immuno deficiency virus infection: antiproteinuric effect of captopril.
    Górriz JL, Rovira E, Sancho A, Ferrer R, Paricio A, Pallardó LM.
    Nephrol Dial Transplant; 1997 Dec 27; 12(12):2796-7. PubMed ID: 9430904
    [No Abstract] [Full Text] [Related]

  • 20. Combined renin angiotensin blockade in childhood steroid-resistant nephrotic syndrome.
    Supavekin S, Surapaitoolkorn W, Tancharoen W, Pattaragarn A, Sumboonnanonda A.
    Pediatr Int; 2012 Dec 27; 54(6):793-7. PubMed ID: 22621380
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.